Related Experiment Video
Updated: Jan 11, 2026

Protocol for Recombinant RBD-based SARS Vaccines: Protein Preparation, Animal Vaccination and Neutralization Detection
Published on: May 2, 2011
Post-authorisation effectiveness and safety study: a multicenter observational study of the effectiveness and safety
Nawal Alkaabi1,2, Salah El Din Hussein Mohamed2, Faduma Mohamed Ismail2
1College of Medicine and Health Science, Khalifa University, Abu Dhabi, United Arab Emirates.
Purpose:
The coronavirus disease 2019 (COVID-19) pandemic led to the rapid development of vaccines to control the spread of infection. The inactivated severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) Sinopharm BIBP vaccine was introduced in the United Arab Emirates (UAE) and registered by the Ministry of Health and Prevention before the final data of the phase III clinical trial was released. Hence, a post-authorization effectiveness and safety study was required to evaluate the effectiveness and safety profile of the vaccine.
Materials And Methods:
An observational Phase IV study was conducted in Sheikh Khalifa Medical City, UAE, for 18 months. The effectiveness of the BIBP vaccine was evaluated in individuals who received at least the first 2 doses and those who received the full vaccine course (with booster dose) based on immunogenicity assessment of anti-SARS-CoV-2 antibodies and protection against COVID-19.
Results:
About 96% of the participants showed positive results for the neutralizing antibody and anti-S antibody against the SARS-CoV-2, 14 days after the second dose of the vaccine. The participants showed similar positive results after the booster vaccine, and the antibodies remained at that level at the one-year follow-up. Only 16 participants who received at least one dose of the vaccine experienced COVID-19. Safety outcomes showed that all serious adverse events reported were unrelated to the vaccine. No death was reported in this study period.
Conclusion:
The inactivated BIBP Sinopharm vaccine proved safe and effective in protecting against COVID-19.
More Related Videos
09:03Rapid In Vivo Assessment of Adjuvant's Cytotoxic T Lymphocytes Generation Capabilities for Vaccine Development
Published on: June 19, 2018
13:47Opsono-Adherence Assay to Evaluate Functional Antibodies in Vaccine Development Against Bacillus anthracis and Other Encapsulated Pathogens
Published on: May 19, 2020
Related Concept Videos
Bioavailability Study Design: Single Versus Multiple Dose Studies
Bioavailability Study Design: Healthy Subjects Versus Patients
Bioequivalence studies: Biowaivers
Pharmacovigilance
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
Vaccinations
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...